TY - JOUR
T1 - Keratoacanthoma
T2 - A Clinico-Pathologic Enigma
AU - Schwartz, Robert A.
AU - Humphreys, Tatyana
PY - 2004/2
Y1 - 2004/2
N2 - BACKGROUND. Keratoacanthoma (KA) is an extraordinary entity. Once considered a benign neoplasm that resembled a highly malignant one (pseudomalignancy), it is now viewed in an opposite light as a cancer that resembles a benign neoplasm (pseudobenignity). OBJECTIVE. The goal was to delineate the malignant potential of this neoplasm based on the author's experience and a review of recent data and research and to emphasize the KA as a possible part of an autosomal dominant familial cancer syndrome, the Muir-Torre syndrome. METHODS. This is a review of the literature. RESULTS. In this work, the KA is reviewed with recent advances emphasized. CONCLUSION. KA is an abortive malignancy that rarely progresses into an invasive SCC. The KA may serve as a marker for the important autosomal dominant familial cancer syndrome, the Muir-Torre syndrome, as a result of a defective DNA mismatch repair gene.
AB - BACKGROUND. Keratoacanthoma (KA) is an extraordinary entity. Once considered a benign neoplasm that resembled a highly malignant one (pseudomalignancy), it is now viewed in an opposite light as a cancer that resembles a benign neoplasm (pseudobenignity). OBJECTIVE. The goal was to delineate the malignant potential of this neoplasm based on the author's experience and a review of recent data and research and to emphasize the KA as a possible part of an autosomal dominant familial cancer syndrome, the Muir-Torre syndrome. METHODS. This is a review of the literature. RESULTS. In this work, the KA is reviewed with recent advances emphasized. CONCLUSION. KA is an abortive malignancy that rarely progresses into an invasive SCC. The KA may serve as a marker for the important autosomal dominant familial cancer syndrome, the Muir-Torre syndrome, as a result of a defective DNA mismatch repair gene.
UR - http://www.scopus.com/inward/record.url?scp=1542318591&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1542318591&partnerID=8YFLogxK
U2 - 10.1097/00042728-200402002-00015
DO - 10.1097/00042728-200402002-00015
M3 - Review article
C2 - 14871228
AN - SCOPUS:1542318591
SN - 1076-0512
VL - 30
SP - 326
EP - 333
JO - Journal of Dermatologic Surgery and Oncology
JF - Journal of Dermatologic Surgery and Oncology
IS - 2 II
ER -